Results 71 to 80 of about 3,725,030 (238)

Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review [PDF]

open access: yesТерапевтический архив
Patients with rheumatic diseases infected with hepatitis B virus (HBV) are difficult to manage not only due to the presence of risk factors for the development and rapid progression of liver cirrhosis, but also due to the likelihood of reactivation of ...
Galina I. Gridneva   +2 more
doaj   +1 more source

Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis. [PDF]

open access: yes, 2009
ObjectiveC-reactive protein (CRP) levels>3 mg/L and>10 mg/L are associated with high and very high cardiovascular risk, respectively, in the general population.
Graf, Jonathan   +3 more
core   +4 more sources

A Serious Puzzle Game to Enhance Adherence to Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Systematic Development Using Intervention Mapping

open access: yesJMIR Serious Games, 2022
BackgroundPatients’ implicit attitudes toward medication need and concerns may influence their adherence. Targeting these implicit attitudes by combining game-entertainment with medication-related triggers might improve medication
Bart PH Pouls   +4 more
doaj   +1 more source

The outcome and cost-effectiveness of nurse-led care in the community for people with rheumatoid arthritis:a non-randomised pragmatic study [PDF]

open access: yes, 2015
To determine the outcome and cost-effectiveness of nurse-led care in the community for people with rheumatoid arthritis (RA)
Abdelhamid   +35 more
core   +1 more source

Responsiveness of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis [PDF]

open access: yes, 2009
Background: The comprehensive International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis (RA) is a selection of 96 categories from the ICF, representing relevant aspects in the functioning of patients ...
Cieza, Alarcos   +5 more
core   +1 more source

Is vaccination against viral hepatitis B safe and immunogenic in patients with rheumatic diseases?

open access: yesСовременная ревматология
Impressive successes have been achieved in the fight against viral hepatitis B (HBV), but victory over this infection has not yet been achieved. According to various estimates, there are 6–12.5 times more patients with resolved HBV who are carriers of ...
G. I. Gridneva   +2 more
doaj   +1 more source

Biological Therapies in Inflammatory Myopathies

open access: yesRambam Maimonides Medical Journal, 2023
Idiopathic inflammatory myopathies (IIM) are a rare group of disorders that feature progressive immune-mediated skeletal muscle destruction along with skin, lung, and joint involvement.
Abd El Haleem Natour, Shaye Kivity
doaj   +1 more source

Patients’ Attitudes and Experiences of Disease‐Modifying Antirheumatic Drugs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Synthesis

open access: yesArthritis care & research, 2018
Nonadherence to disease‐modifying antirheumatic drugs (DMARDS) in rheumatoid arthritis (RA) and spondyloarthritis (SpA) results in increased disease activity and symptoms and poorer quality of life.
A. Kelly   +8 more
semanticscholar   +1 more source

To the problem of extended serological testing for viral hepatitis B in rheumatoid arthritis patients

open access: yesТерапевтический архив
Aim. The objectives of the study: to conduct serologic screening for latent HBV infection in rheumatoid arthritis (RA) patients, to determine the level of protective antibodies to HBsAg in RA patients, and to determine the clinical and laboratory ...
Galina I. Gridneva   +7 more
doaj   +1 more source

Perioperative Management of Patients with Rheumatic Disease: Cardiovascular Risks, Prevention of Infectious and Thromboembolic Complications, Other Conditions

open access: yesАрхивъ внутренней медицины, 2022
In the first part we reviewed the issues of perioperative administration of steroids, disease-modifying antirheumatic drugs, biologics and nonsteroidal anti-inflammatory drugs.
V. A. Lyalina   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy